维普期刊资源整合服务平台（V6.5）

168篇 您的检索式：作者名="Bukowski RM"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Sunitinib在治疗转移性肾细胞癌中的作用显示文摘	Motzer RJ Rini BI Bukowski RM 菅鑫妍	2006	中国处方药2006，，8：	3
2	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC):Impact of crossover on survival (abst) 显示文摘	Eisen T Bukowski RM Staehler M	2006	Proc Am Soc Clin Oncol2006，24，：	1
3	A phase Ⅱ study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma 显示文摘	Hutson TE Bukowski RM	2006	Clin Genitourin Cancer2006，4，4：	1
4	Sorafenib: recent update on activity as a single agent and in combination with interferon-alpha2 in patients with advanced-stage renal cell carcinoma 显示文摘	Reddy GK Bukowski RM	2006	Clin Genitourin Cancer2006，4，4：	1
5	Sunitinib in patients withmetastatic renal cell carcinoma显示文摘	Motzer RJ Kini BI Bukowski RM	2006	JAMA2006，295，21：	1
6	Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma显示文摘	Bukowski RM	2012	Front On- col2012，2，：	1
7	Sunitinib in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
8	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival显示文摘	Eisen T Bukowski RM Staehler M	2006	J Clin Oncol2006，24，：	1
9	Sunitinib in patients with metastatic renal cell carcinoma显示文摘	Motzer RJ Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
10	Axltinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study 显示文摘	RIXE O BUKOWSKI RM MICHAELSON MD	2007	Lancet Oncol2007，8，11：	1
11	Sunidnib in padents with metastatic renal cell carcinoma显示文摘	Motzer RJ Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
12	Sunitinib in patients with metastatic renal cell carcinoma 显示文摘	Motzer RJ Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
13	T-cell adoptive immunotherapy of metastatic renal cell carcinoma显示文摘	Bukowski RM Novick AC	1999	Urology1999，54，：	1
14	Amifostine(ethyol):dosing,administration and patient management guidelines显示文摘	Bukowski RM	1996	Eur J Cancer1996，32，4：	1
15	Sunitinib in pa- tients with metastatic renal cell carcinoma 显示文摘	Motzer R J Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
16	What role do combinations of interferon and targe-ted agents play in the first - line therapy of metastatic renal cellcarcinoma显示文摘	Bukowski RM	2008	Clin Genitourin Cancer2008，6，1：	1
17	Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer:a phase Ⅱ study显示文摘	Rixe O Bukowski RM Michaelson MD	2007	Lancet Oncol2007，8，11：	1
18	Targeted therapy for metastatic renal cell carcinoma显示文摘	Motzer RJ Bukowski RM	2006	J Clin Oncol2006，24，35：	1
19	Systemic therapy for metastatic renal cell carcino-ma in treatment naive patients;a risk - based approach 显示文摘	Bukowski RM	2010	Ex-pert Opin Pharmacother2010，11，14：	1
20	A phaseⅠstudy with neratinib(HKI-272),an irreversible pan Erb B receptor tyrosine kinase inhibitor,in patients with solid tumors显示文摘	Wong KK Fracasso PM Bukowski RM	2009	Clin Cancer Res2009，15，7：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示